Related Experiment Video
Updated: Jun 26, 2026

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
Expansion of plasma MicroRNAs over the first month following human stroke
Matthew A Edwardson1,2, Narayan Shivapurkar3, James Li4
1Department of Neurology, Georgetown University, Washington, DC, USA.
Abstract:
Few have characterized miRNA expression during the transition from injury to neural repair and secondary neurodegeneration following stroke in humans. We compared expression of 754 miRNAs from plasma samples collected 5, 15, and 30 days post-ischemic stroke from a discovery cohort (n = 55) and 15-days post-ischemic stroke from a validation cohort (n = 48) to healthy control samples (n = 55 and 48 respectively) matched for age, sex, race and cardiovascular comorbidities using qRT-PCR. Eight miRNAs remained significantly altered across all time points in both cohorts including many described in acute stroke. The number of significantly dysregulated miRNAs more than doubled from post-stroke day 5 (19 miRNAs) to days 15 (50 miRNAs) and 30 (57 miRNAs). Twelve brain-enriched miRNAs were significantly altered at one or more time points (decreased expression, stroke versus controls: miR-107; increased expression: miR-99-5p, miR-127-3p, miR-128-3p, miR-181a-3p, miR-181a-5p, miR-382-5p, miR-433-3p, miR-491-5p, miR-495-3p, miR-874-3p, and miR-941). Many brain-enriched miRNAs were associated with apoptosis over the first month post-stroke whereas other miRNAs suggested a transition to synapse regulation and neuronal protection by day 30. These findings suggest that a program of decreased cellular proliferation may last at least 30 days post-stroke, and points to specific miRNAs that could contribute to neural repair in humans.
Insights
This study tracked microRNA (miRNA) levels after stroke, finding significant changes in brain-related miRNAs over 30 days. These alterations suggest a shift from cell death to repair processes, offering potential therapeutic targets for stroke recovery.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Stroke triggers complex molecular events impacting neural repair and secondary degeneration.
- MicroRNA (miRNA) expression dynamics during human stroke recovery remain largely uncharacterized.
- Understanding miRNA profiles is crucial for identifying biomarkers and therapeutic targets post-stroke.
Purpose of the Study:
- To characterize miRNA expression profiles in plasma following ischemic stroke in humans.
- To investigate the temporal changes in miRNA expression from acute injury through the early repair phase (5, 15, and 30 days post-stroke).
- To identify specific brain-enriched miRNAs associated with stroke-induced apoptosis and subsequent neuroprotection.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to analyze the expression of 754 miRNAs.
- Plasma samples were collected from discovery (n=55) and validation (n=48) cohorts at 5, 15, and 30 days post-ischemic stroke.
- Samples were compared to age-, sex-, race-, and comorbidity-matched healthy controls.
Main Results:
- Eight miRNAs showed consistent significant alterations across all time points in both cohorts.
- The number of significantly dysregulated miRNAs increased substantially from day 5 (19 miRNAs) to days 15 (50 miRNAs) and 30 (57 miRNAs).
- Twelve brain-enriched miRNAs were significantly altered, with many linked to apoptosis early post-stroke and others suggesting a transition to synapse regulation and neuronal protection by day 30.
Conclusions:
- Stroke induces dynamic changes in plasma miRNA expression, extending beyond the acute phase.
- Specific brain-enriched miRNAs are implicated in the post-stroke transition from cell death to neuroprotective processes.
- These identified miRNAs represent potential biomarkers for stroke progression and targets for future therapeutic interventions aimed at promoting neural repair.
More Related Videos
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
05:40AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
Published on: November 29, 2024